
A look at last week's top stories in the world of pharmacy.

Switching from etanercept to biosimilar was not associated with treatment-emergent adverse events in rheumatoid arthritis.

Manipulating a specific protein could potentially drive tumor cells to self-destruct.

Drug found to slow cyst growth in patients with autosomal dominant polycystic kidney disease.

Top news of the day from across the health care landscape.

Determining how hepatitis C progresses is important when considering therapies and the associated costs for different patient groups.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the best strategies to ensure patient satisfaction.

Bristol-Myers Squibb and Celgene announce FDA clinical trial holds of PD-1 inhibitors being studied in multiple myeloma.

Supermarket chain pharmacies have the highest levels of customer satisfaction in JD Power survey, with Walgreens ranking highest among specialty pharmacies.

Infrared spectroscopy and blood samples provide cheaper, less invasive screening alternative for inflammatory bowel disease.

Bruce A. Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions, discusses the key elements of an effective cancer clinical care pathways program.

Top news of the day from across the health care landscape.

The ACTolog approach targets tumor-specific antigens to fight cancer.

Dietary studies for patients with multiple sclerosis have centered on vitamin D and obesity, but not overall diets.

The destruction from Hurricane Harvey and the looming threat of Hurricane Irma show the importance of accessing prescription drugs during a natural disaster.

Accelerated fibrosis in women with a hepatitis C/HIV co-infection begins as early as pre-menopausal years.

Leaky blood vessels in bone marrow can lead to chemotherapy failure in acute myeloid leukemia.

Allowing patients to control mammography compression may improve stress associated with breast cancer screening.

Top news of the day from across the health care landscape.

Blocking PCSK9 may reduce atherosclerosis and heart disease by harnessing immune mechanisms.

Certain areas within the pharmacy are hotspots for germs and bacteria.

Fingolimod may reduce relapses more effectively than interferon beta-1a in pediatric multiple sclerosis.

Less than one-third of melanomas came from an existing mole.

Patients with breast cancer who are more rational may strongly consider contralateral mastectomy.

Top news of the day from across the healthcare landscape.

Patients who received the shingles vaccine before treatment for arthritis with tofacitinib showed robust immune responses.

The degree of the success for HIV remission vary in different parts of the country.

Cladribine tablets demonstrated sustained clinical efficacy for up to 4 years treating multiple sclerosis.

Novel technology could reduce the number of unnecessary biopsies, ultimately reducing health care costs.

Houston-based specialty pharmacy takes extraordinary measures to demonstrate commitment to their patients during Hurricane Harvey.